Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone
Authors:
- Kimiyuki IkedaKIKimiyuki Ikeda
- Masanori ShiratoriMSMasanori Shiratori
- Hirofumi ChibaHCHirofumi Chiba
- Hirotaka NishikioriHNHirotaka Nishikiori
- Keiki YokooKYKeiki Yokoo
- Atsushi SaitoAtsushi Saito
- Yoshihiro HasegawaYHYoshihiro Hasegawa
- Koji KuronumaKKKoji Kuronuma
- Mitsuo OtsukaMOMitsuo Otsuka
- Gen YamadaGYGen Yamada
- Hiroki TakahashiHTHiroki Takahashi
- 1 October 2017
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 131, 184-191
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: An Update of the 2011 Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2015
- Epidemiologic Survey of Japanese Patients with Idiopathic Pulmonary Fibrosis and Investigation of Ethnic DifferencesAmerican Journal of Respiratory and Critical Care Medicine, 2014
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2014
- Pirfenidone in idiopathic pulmonary fibrosis: the CAPACITY programExpert Review of Respiratory Medicine, 2011
- Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the New MillenniumChest, 2011
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trialsThe Lancet, 2011
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Pirfenidone in idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2009
- Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosisEuropean Journal of Pharmacology, 2008
- Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2005